| David Benjamin Cohen, MD | |
|
227 Medical Park Dr Ste 103, Bridgeport, WV 26330-8421 | |
| (681) 342-3500 | |
| Not Available |
| Full Name | David Benjamin Cohen |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 24 Years |
| Location | 227 Medical Park Dr Ste 103, Bridgeport, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194765180 | NPI | - | NPPES |
| 1017678920001 | Medicaid | PA | |
| 2737408 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD429271 (Pennsylvania) | Secondary |
| 207T00000X | Neurological Surgery | 22547 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wheeling Hospital | Wheeling, WV | Hospital |
| Reynolds Memorial Hospital | Glen dale, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reynolds Memorial Hospital, Inc | 9830184530 | 122 |
| West Virginia University Medical Corporation | 1052224565 | 1613 |
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Droplets emanating from a molecular "nano-tap" would behave very differently from those from a household tap 1 million times larger - researchers at the University of Warwick have found.
The hypothesis that the personal equipment or the uniform might affect the function of the seat belt in a collision was put to test. The study points out that an alternative, professional use of vehicles ought to be more generally considered in relation to the crash safety aspects.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Lipid Therapeutics announces today that it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed with a planned Phase III trial in the US in mild-moderate ulcerative colitis patients. The LT-02 IND was subject to the FDA's customary 30 day review period.
› Verified 2 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Droplets emanating from a molecular "nano-tap" would behave very differently from those from a household tap 1 million times larger - researchers at the University of Warwick have found.
The hypothesis that the personal equipment or the uniform might affect the function of the seat belt in a collision was put to test. The study points out that an alternative, professional use of vehicles ought to be more generally considered in relation to the crash safety aspects.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Lipid Therapeutics announces today that it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed with a planned Phase III trial in the US in mild-moderate ulcerative colitis patients. The LT-02 IND was subject to the FDA's customary 30 day review period.
› Verified 2 days ago
| Entity Name | Reynolds Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518068014 PECOS PAC ID: 9830184530 Enrollment ID: O20040420000896 |
News Archive
Droplets emanating from a molecular "nano-tap" would behave very differently from those from a household tap 1 million times larger - researchers at the University of Warwick have found.
The hypothesis that the personal equipment or the uniform might affect the function of the seat belt in a collision was put to test. The study points out that an alternative, professional use of vehicles ought to be more generally considered in relation to the crash safety aspects.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Lipid Therapeutics announces today that it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed with a planned Phase III trial in the US in mild-moderate ulcerative colitis patients. The LT-02 IND was subject to the FDA's customary 30 day review period.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Benjamin Cohen, MD 420 E North Ave, Suite 302, Pittsburgh, PA 15212-4746 Ph: (412) 359-6200 | David Benjamin Cohen, MD 227 Medical Park Dr Ste 103, Bridgeport, WV 26330-8421 Ph: (681) 342-3500 |
News Archive
Droplets emanating from a molecular "nano-tap" would behave very differently from those from a household tap 1 million times larger - researchers at the University of Warwick have found.
The hypothesis that the personal equipment or the uniform might affect the function of the seat belt in a collision was put to test. The study points out that an alternative, professional use of vehicles ought to be more generally considered in relation to the crash safety aspects.
As a part of the COMMUNITY (COVID-19 Immunity) study, researchers from Sweden reveal long-lasting IgG neutralizing antibody response against spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the vast majority of convalescent individuals – even after asymptomatic or mild infection. Their results are currently available on medRxiv* preprint server.
The TACKLE CANCER FOUNDATION wants to call attention to important news for patients with the blood cancer multiple myeloma. A new study shows patients benefit from daily medical treatments to keep their cancer in check after they have had a stem cell (bone marrow) transplant. The current standard of care is to give patients the transplant and then hold off on additional treatment until they relapse. The new study shows continuous treatment with the oral drug REVLIMID following the transplant significantly prolongs remission, increasing time to disease progression.
Lipid Therapeutics announces today that it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed with a planned Phase III trial in the US in mild-moderate ulcerative colitis patients. The LT-02 IND was subject to the FDA's customary 30 day review period.
› Verified 2 days ago
Vincent J Miele, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Drive, Suite 401, Uhc Neurosurgery & Spine Center, Bridgeport, WV 26300 Phone: 681-342-3500 Fax: 681-342-3561 | |
Dr. Richard Allen Douglas, M.D.,F.A.C.S. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 527 Medical Park Drive, Suite 401, Bridgeport, WV 26330 Phone: 681-342-3500 Fax: 681-342-3561 | |
Dr. Bill D. Underwood, M.D., PH.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 227 Medical Park Dr Ste 103, Bridgeport, WV 26330 Phone: 681-342-3500 Fax: 681-342-3561 | |
Mary Anne Varner, APRN Neurological Surgery Medicare: Medicare Enrolled Practice Location: 227 Medical Park Drive, Suite 103, Bridgeport, WV 26330 Phone: 681-342-3513 |